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Abstract
Background: The aim of this meta-analysis was to compare the long-term efficacy of diet plus exercise (D + E) vs.
diet (D), D + E vs. exercise (E) and D vs. E on anthropometric outcomes and cardiovascular risk factors in overweight
and obese participants.
Methods: Electronic searches were performed in MEDLINE and the Cochrane Central Register of controlled trials.
Inclusion criteria were as follows: body mass index ≥25 kg/m2 and a minimum intervention period including
follow-up of ≥12 months. Outcomes of interest were as follows: anthropometric parameters, blood lipids, blood
pressure and cardiorespiratory fitness. Pooled effects were calculated using pairwise random effects and Bayesian
random effects network meta-analysis. Results of the corresponding fixed effects models were compared in sensitivity
analyses.
Results: Overall, 22 trials (24 reports) met the inclusion criteria and 21 (including 3,521 participants) of them were included
in the quantitative analysis. As compared with D, D + E resulted in a significantly more pronounced reduction in body
weight [mean differences (MD): −1.38 kg, 95% confidence interval (CI) −1.98 to −0.79], and fat mass (MD: −1.65 kg, 95%
CI −2.81 to −0.49], respectively. When comparing D + E with E, MD in change of body weight (−4.13 kg, 95% CI −5.62
to −2.64), waist circumference (−3.00 cm, 95% CI −5.81 to −0.20), and fat mass (−3.60 kg, 95% CI −6.15 to −1.05) was in
favour of combined diet and exercise, respectively. Comparing E vs. D, diet resulted in a significantly more pronounced
decrease in body weight (MD: −2.93 kg, 95% CI −4.18 to −1.68), and fat mass (MD: −2.20 kg, 95% CI −3.75 to −0.66).
D + E yielded also the greatest reductions with respect to blood lipids and blood pressure when compared to single
applications of D and E, respectively. Results from the network meta-analyses confirmed these findings.
Conclusions: Moderate-quality evidence from the present network meta-analysis suggests that D + E can be highly
recommended for long-term obesity management. Furthermore, the evidence suggests a moderate
superiority of D over E with respect to anthropometric outcomes.
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Background
In 2008, an estimated 1.4 billion adults were overweight
meaning that the prevalence of obesity has more than dou-
bled since 1980. Of these, over 200 million men and nearly
300 million women were obese [1]. Overweight (body mass
index (BMI): ≥25 kg/m2) and obesity (BMI: ≥30 kg/m2) are
independent risk factors for non-communicable diseases,
especially cardiovascular diseases (CVD) and several types
of cancer [2,3]. Exercise and diet are cornerstones in the
prevention and management of overweight and obesity.
Reductions of fat mass, primarily visceral adipose tissue,
are major objectives. Energy expenditure increases with
physical activity, especially with aerobic exercise or
combined aerobic and resistance training [4,5]. Caloric
restriction induces weight loss by negative energy bal-
ance. Evidence from meta-analyses indicates that low-
carbohydrate diets have slightly more favourable effects
on body weight as compared to low-fat diets. Neverthe-
less, independent of macronutrient composition, the
long-term health effects of diets are as yet unknown,
and the observed outcomes appear of little clinical signifi-
cance [6-9]. Regarding exercise training, results from
recent network meta-analyses indicate that combined
aerobic and resistance exercise is the most effective
training modality in the treatment/prevention of over-
weight/obesity and type 2 diabetes mellitus [4,10].
Previous meta-analyses by Shaw et al. [11] (including
trials: ≥3 months length) as well as Wu et al. [12]
(≥6 months) focused on intervention trials comparing
diet plus exercise (D + E) vs. diet (D) on body weight
and BMI as outcome parameters, but anthropometric
outcomes such as waist circumference, fat mass, waist
to hip ratio and cardiovascular risk factors (blood lipids,
blood pressure and cardiorespiratory fitness) were not in-
cluded. To the best of our knowledge, to date, no meta-
analysis has compared the head-to-head and indirect
long-term (≥12 months) effects of D + E vs. D vs. E on an-
thropometric parameters and cardiovascular risk factors.
Therefore, the aim of this study was to conduct a system-
atic review with pairwise and network meta-analysis of
randomized controlled trials to combine the direct and in-
direct evidence on the efficacy of different lifestyle long-
term weight-reducing interventions on anthropometric
parameters, blood lipids, blood pressure and cardiorespi-
ratory fitness in participants with a BMI ≥25 kg/m2.
Methods
The review protocol has been registered in PROSPERO
International Prospective Register of Systematic Reviews (crd.
york.ac.uk/prospero/index.asp Identifier: CRD42013003906).
Literature search
Queries of literature were performed using the electronic
databases MEDLINE (between 1966 and June 2014) and
the Cochrane Trial Register (until June 2014) with no re-
strictions to language and calendar date using the follow-
ing search terms: (“lifestyle” OR “exercise” OR “diet”) AND
(“body weight” OR “lipids”) AND (“randomized controlled
trial” OR “randomized” OR “clinical trials as topic” OR
“placebo” OR “randomly” OR “trial”) NOT (“animals”
NOT “humans”). Moreover, the reference lists from re-
trieved articles and systematic reviews and meta-analyses
were checked to search for further relevant studies. This
systematic review was planned, conducted and reported in
adherence to standards of quality for reporting meta-
analyses [13]. Literature search was conducted independ-
ently by two authors (LS, GH), with disagreements resolved
by consensus.
Eligibility criteria
Studies were included in the meta-analysis if they met all
of the following criteria: (i) randomized controlled design;
(ii) minimum intervention period including follow-up of
12 months; (iii) body mass index: ≥25 kg/m2; (iv) compar-
ing D + E vs. D or/and D + E vs. E or/and D vs. E; (v)
assessment of “primary outcome” markers: body weight
(BW), waist circumference (WC), waist-to-hip ratio
(WHR), fat mass (FM) and “secondary outcome” markers:
total cholesterol (TC), low-density lipoprotein cholesterol
(LDL-C), high-density lipoprotein cholesterol (HDL-C),
triacylglycerols (TG), diastolic blood pressure (DBP), sys-
tolic blood pressure (SBP) and cardiorespiratory fitness
(VO2 max); (vi) participants with coronary heart disease
were excluded; (vii) report post-intervention mean values
(if not available change-from-baseline value scores were
used) with standard deviation (or basic data to calculate
these parameters: standard error or 95% confidence inter-
val (CI)) according to the Cochrane Handbook [14]; and
(viii) ≥19 years of age.
Risk of bias assessment
Full copies of studies were independently assessed for
methodological quality by two authors (LS, GH) using
the risk of bias assessment tool by the Cochrane Collab-
oration. The following sources of bias were detected:
selection bias (random sequence generation, allocation
concealment), performance/detection bias (blinding of
participants and personnel, blinding of outcome assess-
ment), attrition bias (incomplete data outcome) and report-
ing bias (selective reporting) (Figure 1) [14,15].
Data extraction and statistical analysis
The following data were extracted from each study: the first
author’s last name, publication year, study length (including
follow-up), participant’s sex and age, BMI, sample size,%
T2D, intervention type, characteristics of dietary interven-
tion, characteristics of exercise intervention, dropout rates,
post-intervention mean values or change-from-baseline
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value scores with corresponding standard deviation.
Data extraction was performed by one author (LS).
Separate pairwise meta-analyses were first used to com-
pare all lifestyle interventions. Network meta-analysis was
then used to synthesize all the available evidence [16].
Network meta-analysis methods are extensions of the
standard pairwise meta-analysis model which enable sim-
ultaneous comparison of multiple interventions whilst
preserving the internal randomization of individual trials.
They have the advantage of adequately accounting for the
correlation in relative effect estimates from three-arm tri-
als as well as providing a single coherent summary of all
the evidence.
Pairwise meta-analyses
For each outcome measure of interest and for each pair
of treatments, a random effects inverse variance meta-
analysis was performed in order to determine the pooled
effect of the intervention in terms of mean differences
(MDs) between the post-intervention (or change-from-
baseline) values of the different lifestyle interventions
[14]. Data were pooled if outcomes were reported by at
least three studies. Heterogeneity between trial results
was tested with a standard χ2 test. The I2 parameter was
used to quantify any heterogeneity: I2 = [(Q − d.f.)]/Q ×
100%, where Q is the χ2 statistic and d.f. is its degrees of
freedom. A value for I2 > 50% was considered to repre-
sent substantial heterogeneity [17]. As study characteris-
tics were expected to differ, statistical heterogeneity was
also expected and a random effects model was used to
estimate MDs with 95% CIs. In addition, sensitivity ana-
lyses were planned to further elucidate the potential influ-
ence of heterogeneity due to different study characteristics
on the outcome of the pairwise meta-analysis (such as
study length, age of participants, risk of bias). Forest plots
were generated to illustrate the study-specific effect sizes
along with a 95% CI. To determine the presence of publi-
cation bias, we assessed the symmetry of the funnel plots
in which mean differences were plotted against their cor-
responding standard errors taking into account the rec-
ommendation by Sterne et al. [18], i.e. that testing for
funnel plot asymmetry should only be conducted if the
number of studies is ten or larger. Additionally, Begg’s and
Egger’s regression tests were performed to detect small
study effects [19,20].
Network meta-analyses
To account for the expected between-study heterogen-
eity, random effects network meta-analysis models were
used. For each outcome, a common between-study het-
erogeneity parameter was assumed to reflect the vari-
ability between studies of all interventions.
Model fit was assessed by comparing the number of
data points to the posterior mean of the residual deviance
Figure 1 Risk of bias assessment tool. Across trials, information is
either from trials at a low risk of bias (green), or from trials at unclear
risk of bias (yellow), or from trials at high risk of bias (red).
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[16] (these values should be similar in a well-fitting model).
Pooled effect sizes from the network meta-analyses are
presented as posterior medians and 95% credible intervals
(CrI) (i.e. Bayesian equivalent of confidence intervals) in
the appropriate units along with the estimated between-
study heterogeneity and its 95% CrI. Treatments were
ranked best, second best and third best based on their
efficacy.
To assess sensitivity to the choice of random or fixed
effects network meta-analysis models, the two models
were compared using the deviance information criteria
for each outcome [16,21] which account for both model
fit and complexity. The fixed effects model was consid-
ered adequate when its deviance information criterion
(DIC) was lower than the random effects model (differ-
ences >3 or 5 are considered meaningful) [16,21]. Mean
differences for the fixed effects network meta-analysis
(NMA) model are also presented for comparison.
Computation
For pairwise meta-analyses, data were analysed using the
Review Manager 5.1 software, provided by the Cochrane
Collaboration (http://ims.cochrane.org/revman). Network
meta-analyses were conducted using Markov chain Monte
Carlo (MCMC) simulation implemented with the open-
source software WinBUGS, version 1.4.3 [22]. The Win-
BUGS code used is freely available online (program
“TSD2-5aRE_Normal_id.odc” for the random effects
models and “TSD2-5aFE_Normal_id.odc” for the fixed
effects models) [16,23]. Minimally informative normal
priors (with mean zero and variance 10,000) were used for
all treatment effect parameters, and a uniform (0, 150)
prior was used for the between-study standard deviation
(heterogeneity) parameter. These priors were considered
non-informative over the expected range of data. Sensitiv-
ity to the prior on the between-study heterogeneity was
assessed by varying the upper bound of the uniform distri-
bution, but there was no meaningful change in relative ef-
fects or overall conclusions.
Three MCMC chains were used to assess convergence
using Brooks-Gelman-Rubin plots and by inspection of
the trace plots [24]. Convergence was achieved after
20,000 iterations for all outcomes. Posterior summaries
were then obtained from further simulation of 50,000 it-
erations in each of the three chains (150,000 in total),
resulting in a small Monte Carlo error.
Treatments were ranked at each iteration (post-con-
vergence) according to their efficacy, where the “best”
treatment was the one with the most favourable out-
come (which could be described by a higher or lower
MD, depending on the outcome).
The potential for inconsistency was assessed by in-
spection of the network plots. Where there was a poten-
tial for inconsistency, i.e. where there were independent
sources of evidence informing direct and indirect esti-
mates, Bayesian p values for the difference between dir-
ect and indirect evidence were calculated using the node
split method [25,26] implemented in R through GeMTC
[27], and direct and indirect estimates were compared.
Results
In order to ease interpretation of results, the following
changes would be considered to be a benefit: BW, decrease;
WC, decrease; FM, decrease; WHR, decrease; TC, decrease;
LDL-C, decrease; HDL-C, increase; TG, decrease; DBP,
decrease; SBP, decrease; VO2 max, increase; altogether,
22 trials (24 reports) met the inclusion criteria and 21
of them were included in the quantitative analysis
[28-52]. The detailed steps of the meta-analysis article
selection process are given as a flow chart in Figure 2, and
full search strategy for PUBMED and the Cochrane Trial
Register is given in Additional file 1.
All studies included were randomized controlled trials
(RCTs) with a duration ranging between 12 and 72 months,
published between 1988 and 2013 and enrolling a total of
3,521 participants, 680 of them being participants with
T2D. The mean age varied between 35 and 70 years and
the BMI between 25.6 and 38.2 kg/m2. Seventeen trials
compared D + E vs. D, 11 compared D + E vs. E and 14
compared D vs. E. General study characteristics are sum-
marized in Table 1. Regarding the dietary interventions, a
major part of the included trials recommended energy-
reduced low-fat diets (≤30% fat of total energy), low in sat-
urated fat, and increased intakes of fruit, vegetables and
fibre. Exercise prescription was partly supervised and in-
cluded aerobic exercise (i.e. jogging, walking, flexibility, cir-
cuit training) and resistance training, overall 50%–85% of
maximal heart rate.
The direct pairwise and network pooled estimate of ef-
fect size for the effects of D + E vs. D, D + E vs. E and D
vs. E on anthropometric outcomes, blood lipids, blood
pressure and cardiorespiratory fitness are summarized in
Table 2.
Anthropometric outcomes/cardiorespiratory fitness
Diet + exercise vs. diet
The weighted mean difference in change of BW [MD:
−1.38 kg (95% CI −1.98 to −0.79), I2 = 0%], WC [MD:
−1.68 cm (95% CI −2.66 to −0.70), I2 = 0%], WHR
[MD: −0.01 U (95% CI −0.02 to −0.01), I2 = 0%] and FM
[MD: −1.65 kg (95% CI −2.81 to −0.49), I2 = 61%] was signifi-
cantly more pronounced in the D+E group as compared to
D, respectively. Furthermore, the D+E group revealed sig-
nificantly more prominent increases in cardiorespiratory
fitness (measured as VO2 max) [MD: 3.61 ml/kg/min
(95% CI 2.07 to 5.14), I2 = 88%] and HDL cholesterol
[MD: 1.62 mg/dl (95% CI 0.28 to 2.95), I2 = 51%] as well
as decreases in TG [MD: −10.08 mg/dl (95% CI −17.38
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to −2.79), I2 = 0%] and DBP [MD: −1.20 mmHg (95%
CI −2.26 to −0.15), I2 = 28%]. In contrast, changes ob-
served for TC, LDL-C and SBP did not differ signifi-
cantly between both groups.
Diet + exercise vs. exercise
Comparing D + E vs. E, a significantly more distinctive
reduction in BW [MD: −4.13 kg (95% CI −5.62 to −2.64),
I2 = 77%], WC [MD: −3.00 cm (95% CI −5.81 to −0.20),
I2 = 69%], WHR [MD: −0.01 U (95% CI −0.02 to −0.00), I2 =
15%] and FM [MD: −3.60 kg (95% CI −6.15 to −1.05), I2 =
92%] could be observed in the D + E group. Rise of VO2
max was significantly more pronounced in the D+ E group
as well [MD: 2.13 ml/kg/min (95% CI 1.52 to 2.74), I2 = 9%].
With respect to blood lipids, TC [MD: −11.36 mg/dl (95%
CI −15.93 to −6.79), I2 = 0%], LDL-C [MD: −10.03 mg/dl
(95% CI −14.28 to −5.78), I2 = 8%], DBP [MD: −2.06 mmHg
(95% CI −3.39 to −0.72), I2 = 0%] and SBP [MD:
−2.84 mmHg (95% CI −4.54 to −1.13), I2 = 0%] were
reduced more substantially following combined D + E
when compared to single E interventions. No significant
differences could be observed for HDL-C and TG.
Diet vs. exercise
Following D vs. E comparisons, reductions in BW
[MD: −2.93 kg (95% CI −4.18 to −1.68), I2 = 74%], FM
[MD: −2.20 kg (95% CI −3.75 to −0.66), I2 = 82%],
HDL-C [MD: −0.96 mg/dl (95% CI −1.88 to −0.04), I2 =
0%] and SBP [MD: −2.19 mmHg (95% CI −4.23 to −0.15),
I2 = 25%] were significantly more pronounced in the D
group. WC, WHR, TC, LDL-C and cardiorespiratory
fitness were not affected in a different fashion by either
D or E.
Network meta-analysis
Additional file 1: Figure S1 shows the network of included
trials. The pooled estimates of effect size for the comparison
of D + E vs. D vs. E using both direct and indirect evidence
on anthropometric outcomes, blood lipids, blood pressure
and cardiorespiratory fitness are summarized in Table 2.
Both D + E and D were significantly more effective in
reducing BW and FM when compared to E alone. D + E
turned out to be the most effective lifestyle intervention
with respect to reduction of BW, WC, FM, TC, LDL-C,
TG, DBP, SBP and increasing HDL-C. D + E resulted in
Records identified through database searching: 
MEDLINE: 10612
Cochrane Register of Trials: 7883
Additional records identified through other 
sources 
(n =1) 
Records screened (title/abstracts)
(n=18496) Records excluded: duplicates, non-
human studies, no-English articles,  
redundant publications, no diet or 
exercise or diet plus exercise group, no 
appropriate study design
(n=18407)
Full-text articles assessed for 
eligibility 
(n =89)
Full-text articles excluded, with reasons (n =65)
Participants not overweight (n=8)
Intervention/follow-up time <12 months (n=24)
no diet or exercise or diet plus exercise group 
(n=32)
lifestyle intervention 8-12 weeks post-partum (n=1)Studies included in qualitative 
synthesis 
n = 22 (24 reports)
Studies included in quantitative 
synthesis (meta-analysis)
n = 21 (23 reports)
Figure 2 Flow diagram.
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Table 1 General study characteristics
Reference Sample size Age (years) Duration of the active
intervention (follow-up)
Study design Dietary intervention Dropout
Baseline BMI (kg/m2) Female (%) Exercise prescription
% diabetics
Anderssen et al. [40]
Reseland et al. [41]
166 40 12 months D + E vs. D vs. E D: increased fish, fruit and vegetables and fibre, reduce
intake of sugar and SFA, no heavy evening meal
D + E: 3%
D: 5%
28.9 0% (0 months)
E: 9%
E: supervised weekly, aerobic training (strength, flexibility,
circuit training, jogging), 60%–80% of peak heart rate0%
Andrews et al. [42] 494 60 12 months D + E vs. D D: aimed at enabling patients to lose 5%–10% of their
initial body weight, based on UK dietary guidelines
E: asked to do at least 30-min brisk walking on at least
5 days per week
D + E: 2%
D: 1%
31.55 35% (0 months)
100%
Borg et al. [43] 82 42.6 8 months D + E vs. D D: low-fat diet D + E: 18%
D: 1%32.9 0% (23 months) E: supervised weekly in group, reached 50%–60% of MHR,
included two groups: (1) walking, expended 1,000 kcal
per week, and (2) walking, expended 2,000 kcal per week
n.d.
Brekke et al. [44] 49 43 12 months D + E vs. D D: Nordic Nutrition Recommendation in addition increase
of low GI food
D + E: 17%
25.6 33% (12 months)
E: the goal to increase physical activity through walking
or other more intensive activities for at least 30 min, four
to five times per week
D: 4%100%
Christensen et al. [52] 28 63 17 months D vs. E D: the goal of the dietary intervention was to produce
and maintain a weight loss of at least 10%
D: 14%
E: 19%
E: exercise intervention consisted of a warm-up phase
(10 min), a circuit training phase (45 min) and a cool
down/stretching phase four periods of 12 weeks and
one period of 4 weeks (total 52 weeks). The aim was to
gradually translate the intervention from facility-based
exercises to home-based exercises
37.05 81.3 (0 months)
0%
Fogelholm et al. [45] 82 35 13 months D + E vs. D D: low-fat diet D + E: 2%
D: 3%
34 100% (11 months) E: supervised weekly in group, reached 50%–60% of MHR,
included two groups: (1) walking, expended 1,000 kcal per
week, and (2) walking, expend 2,000 kcal per week0%
Foster-Schubert et al. [46] 351 58 12 months D + E vs. D vs. E D: total daily energy intake 1,200–2,000 kcal/day on baseline
weight <30% fat and 10% reduction in body weight by
6 months with maintenance thereafter for 12 months
D + E: 8%
D: 11%
E: 9%
E: ≥45 min of moderate-to-vigorous intensity exercise,
5 days/week (225 min/week) for 12 months; supervised;
70%–85% of MHR
28.6 100% (0 months)
0%
Messier et al. [51] 238 68.7 18 months D + E vs. D vs. E D: the goal of intervention was to produce and maintain
an average weight loss of 5% baseline body weight. The
intervention was divided into three phases: intensive,
transition and maintenance
D + E: 24%
34.3 73% (0 months)Nicklas et al. [47]
9%
D: 23%
E: 20%
E: exercise consisted of an aerobic phase, a resistance
training phase, a second aerobic phase and a cooling
down phase
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Table 1 General study characteristics (Continued)
Messier et al. [50] 454 66 18 months D + E vs. D vs. E D: diet was based on partial meal replacements, including
up to two meal replacement shakes per day; for the third
meal, participants followed a weekly menu plan and
recipes that were 500 to 750 kcal, low in fat and high in
vegetables; initial diet plan provided an energy intake
deficit of 800 to 1,000 kcal/day
D + E: 11%
33.6 72% (0 months) D: 15%
13% E: 11%
E: exercise was conducted for 1 h on 3 days/week for
18 months; programme consisted of aerobic walking
(15 min), strength training (20 min), a second aerobic
phase (15 min) and cool down (10 min)
Pan et al. [48] 397 44.4 72 months D + E vs. D vs. E D: caloric intake at 25–30 kcal/kg of BW, increased
vegetable intake and reduced intake of sugars, using
individual goals
D + E: 8%
25.6 47% (0 months) D: 8%
0%, 100% IGT E: increased the amount of exercise at least 1 U/day and
U/day for those less than 50 years old with no evidence of
heart disease or arthritis. The rate of increase and type of
exercise depending on age, past exercise pattern and
existence for heart problem other than IGT
E: 8%
Pritchard et al. [39] 39 44.25 12 months D vs. E D: low-fat diet D: 0%
E: aerobic exercise; minimum participation was three
sessions of 30 min per week. 65%–75% of MHR was
recommended to achieve maximum weight loss
E: 0%29.1 0% (0 months)
0%
Racette et al. [38] 45 57.2 12 months D vs. E D: decrease energy intake by 16% for the initial 3 months
and by 20% for the remaining 9 months; macronutrient
composition was flexible
D: 4%
E: 4%
37.2 63% (0 months)
0% E: the goal of the E intervention was to induce an energy
deficit comparable to the CR intervention by increasing
daily energy expenditure through exercise without
changing caloric intake. Exercise physiologists and trainers
worked with ex-participants individually to establish and
monitor their exercise routines
Skender et al. [37] 61 45 12 months D + E vs. D vs. E Da: help your heart eating plan; well-balanced,
low-cholesterol eating plan
D + E: 50%
35 48% (12 months)
E: supervised weekly although group brisk walking at a
level of felt “vigorous” not “strenuous”, 45 min,
4–5 times/week
D: 65%
0% E: 42%
Snel et al. [36] 27 57.5 4 months D + E vs. D D: 4 months: 450 kcal/day (consisting of three sachets of
Modifast); weight maintenance: 1,800 kcal
D + E: 0%
D: 0%
37 48% (14 months)
100% E: 4 days training at home for 30 min at 70% of maximum
aerobic capacity on a cyclo-ergometer and 1 h in hospital
training under the supervision of a physiotherapist
Stefanick et al. [35] 276 56.9/47.8 12 months D + E vs. D vs. E D: NCEP step 2 diet D + E: 3%
26.3/27 48% (0 months) E: supervised weekly, aerobic exercise =16-km jogging
per week
D: 3%
0% E: 3%
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Table 1 General study characteristics (Continued)
Villareal et al. [34] 80 70 12 months D + E vs. D vs. E D: balance diet with an energy deficit of 500 to 750 kcal.
The diet contained 1 g of high-quality protein/kg of BW
per day
D + E: 11%
37 61% (0 months) D: 15%
n.d. E: 12%E: three supervised exercise training sessions per week.
Each session was 90 min in duration and consisted of
aerobic and resistance exercise and exercise to improve
flexibility and balance
Volpe et al. [33] 90 44.4 6 months D + E vs. D vs. E D: intensive (weekly) nutritional classes (1–3 months) D + E: n.d.
E: supervised training on Nordic Track™ indoor skiing
apparatus, 3–4 days per week, 30 min for 6 weeks
30.5/35.3 51% (6 months)
0%
D: n.d.
E: n.d.
Wadden et al. [32] 77 42 12 months D + E vs. E D: conventional diet with 1,200–1,500 kcal/day D + E: 22%
36.5 100% (0 months) E: supervised weekly in a group, 1 h, two times per week,
included in three exercise groups: (1) aerobic, (2) strength
and (3) combined training
E: 22%
0%
Wing et al. [29] 114 45.5 24 months D + E vs. D vs. E D: participants were asked to follow an 800–100 kcal/day
diet, with 20% of calories as fat, exactly as prescribed for
1–8 weeks of the programme. Gradually more flexible with
calorie goals adjusted to 1,200–1,500 kcal/day at week 16.
Subject attended weekly group meetings for the first
6 months
D + E: 20%
D: 5%
E: 16%
E: supervised by exercise physiologists weekly in a group.
Mainly brisk walking, 3 miles, five times per week, total
activity gradually increased to 1,500 kcal per week
35.9 79% (0 months)
0%
Wing et al. [30] 30 55.56 12 months D + E vs. D D: daily calorie goal designed to produce approximately
1 kg/week weight loss. Low-fat diet
D + E: 13%
38.2 70% (0 months) D: 0%
100% E: all participants exercised twice a week as a group and
once a week on their own, with each exercise session
lasting approximately 1 h
Wood et al. [49] 152 39.1/40.3 12 months D + E vs. D Db: NCEP step 1 diet D + E: 14%
E: aerobic exercise (brisk walking and jogging) that met
3 days a week, 60%–80% of MHR for 25–45 min per time
(by the fourth month of the study)
27.9/30.7 48% (0 months) D: 13%
0%
Wood et al. [28] 89 44.1 12 months D vs. E D: individual prescription designed to reduce baseline
total body fat by one third over a 9-month period
D: 4%
E: 2%n.d 0% (0 months)
E: supervised exercise programme and individual
prescriptions based on estimates of the amount of
energy necessary to decrease total body fat
progressively by one third over 9 months
0%
BMI body mass index, BW body weight, CR caloric restriction, D diet, E exercise, GI glycaemic index, IGT impaired glucose tolerance, MHR maximal heart rate, NCEP National Cholesterol Education Program, SFA
saturated fat, UK United Kingdom; n.d. no data.
aSkender et al. [37]: 50% CH, 30% F, 20% P, low cholesterol.
bWood et al. [49]: 55% CH, 30% F, <10% SFA, <300 mg/day.
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a high (>75%) probability to be the best for most out-
comes. There is greater uncertainty regarding which
treatment is the best for HDL-C, although again D + E
yielded the highest probability of being the best. D turned
out be the second effective lifestyle intervention for BW,
WC, FM, TC and DBP (>75% probability).
There was potential for inconsistency in the networks for
all outcomes except WHR (Additional file 1: Figure S1).
Table 2 Estimates (direct pairwise and network meta-analysis, random effects models) of effect size (95% confidence
intervals/95% credible intervals) expressed as mean difference for the effects of diet + exercise vs. diet, diet + exercise
vs. exercise and diet vs. exercise on anthropometric outcomes, blood lipids, blood pressure and cardiorespiratory
fitness and between-study heterogeneity variance (τ2/τ)
Outcomes No. of studies Sample size MD 95% CI τ2 I2 MD 95% CrI τ 95% CrI
D + E vs. D
BW (kg) 17 2,317 −1.38 [−1.98, −0.79] 0.00 0% −1.38 [−2.62, −0.17] 2.06 [1.37, 2.96]
WC (cm) 8 1,124 −1.68 [−2.66, −0.70] 0.00 0% −1.69 [−3.32, −0.20] 1.36 [0.07, 3.43]
FM (kg) 9 1,012 −1.65 [−2.81, −0.49] 1.95 61% −1.89 [−3.44, −0.43] 2.08 [1.29, 3.24]
WHR (U) 6 646 −0.01 [−0.02, −0.01] 0.00 0% −0.01 [−0.05, 0.03] 0.06 [0.04, 0.10]
TC (mg/dl) 9 1,175 −2.19 [−7.84, 3.46] 54.09 62% −2.51 [−7.61, 2.29] 5.42 [0.86, 10.84]
LDL-C (mg/dl) 8 1,147 −0.93 [−6.14, 4.27] 45.03 65% −1.54 [−6.16, 3.14] 5.29 [1.26, 9.97]
HDL-C (mg/dl) 9 1,175 1.62 [0.28, 2.95] 2.46 51% −1.29 [−1.38, 3.86] 4.03 [2.38, 6.33]
TG (mg/dl) 9 1,175 −10.08 [−17.38, −2.79] 0.00 0% −9.90 [−19.98, −0.96] 7.28 [0.37, 19.4]
DBP (mmHg) 7 1,099 −1.20 [−2.26, −0.15] 0.74 28% −1.10 [−2.34, 0.01] 0.92 [0.04, 2.45]
SBP (mmHg) 7 1,099 −0.24 [−1.45, 0.97] 0.00 0% −0.39 [−1.89, 1.01] 0.87 [0.04, 2.62]
VO2 max (ml/kg/min) 6 810 3.61 [2.07, 5.14] 4.19 88% 3.75 [2.28, 5.32] 1.94 [1.13, 3.18]
D + E vs. E
BW (kg) 9 1,350 −4.13 [−5.62, −2.64] 4.36 77% −4.32 [−5.74, −2.90] 2.06 [1.37, 2.96]
WC (cm) 3 409 −3.00 [−5.81, −0.20] 5.24 69% −3.45 [−5.32, −1.23] 1.36 [0.07, 3.43]
FM (kg) 5 690 −3.60 [−6.15, −1.05] 8.82 92% −3.87 [−5.61, −2.18] 2.08 [1.29, 3.24]
WHR (U) 4 420 −0.01 [−0.02, −0.00] 0.00 15% −0.007 [−0.06, 0.04] 0.06 [0.04, 0.10]
TC (mg/dl) 4 420 −11.36 [−15.93, −6.79] 0.00 0% −7.50 [−13.47, −1.39] 5.42 [0.86, 10.84]
LDL-C (mg/dl) 4 420 −10.03 [−14.28, −5.78] 2.22 8% −5.90 [−11.39, −0.23] 5.29 [1.26, 9.97]
HDL-C (mg/dl) 4 420 −0.34 [−2.82, 2.14] 6.80 76% 0.17 [−3.14, 3.32] 4.03 [2.38, 6.33]
TG (mg/dl) 4 420 −11.18 [−26.99, 4.62] 138.3 38% −13.34 [−25.92, −2.12] 7.28 [0.37, 19.4]
DBP (mmHg) 4 420 −2.06 [−3.39, −0.72] 0.00 0% −2.22 [−3.93, −0.74] 0.92 [0.04, 2.45]
SBP (mmHg) 4 420 −2.84 [−4.54, −1.13] 0.00 0% −2.70 [−4.57, −0.85] 0.87 [0.04, 2.62]
VO2 max (ml/kg/min) 5 645 2.13 [1.52, 2.74] 0.05 9% 2.24 [0.57, 3.90] 1.94 [1.13, 3.18]
D vs. E
BW (kg) 13 1,638 −2.93 [−4.18, −1.68] 3.70 73% −2.93 [−4.20, −1.66] 2.06 [1.37, 2.96]
WC (cm) 4 539 −1.75 [−4.12, 0.62] 4.80 71% −1.76 [−3.48, 0.44] 1.36 [0.07, 3.43]
FM (kg) 9 964 −2.20 [−3.75, −0.66] 4.66 82% −1.97 [−3.45, −0.45] 2.08 [1.29, 3.24]
WHR (U) 4 414 −0.00 [−0.01, 0.01] 0.00 16% 0.002 [−0.05, 0.05] 0.06 [0.04, 0.10]
TC (mg/dl) 7 665 −3.91 [−8.11, 0.30] 9.04 22% −4.98 [−10.22, 0.64] 5.42 [0.86, 10.84]
LDL-C (mg/dl) 7 665 −3.19 [−6.85, 0.48] 6.45 21% −4.36 [−9.25, 0.70] 5.29 [1.26, 9.97]
HDL-C (mg/dl) 7 665 −0.96 [−1.88, −0.04] 0.00 0% −1.12 [−4.06, −1.76] 4.03 [2.38, 6.33]
TG (mg/dl) 7 665 −3.80 [−12.21, 4.62] 0.00 0% −3.44 [−13.99, 6.65] 7.28 [0.37, 19.4]
DBP (mmHg) 6 573 −1.33 [−3.00, 0.35] 11.19 37% −1.12 [−2.67, 0.31] 0.92 [0.04, 2.45]
SBP (mmHg) 6 578 −2.19 [−4.23, −0.15] 2.07 25% −2.31 [−4.10, 0.51] 0.87 [0.04, 2.62]
VO2 max (ml/kg/min) 6 677 −1.16 [−2.42, 0.09] 2.17 80% −1.15 [−3.16, 0.04] 1.94 [1.13, 3.18]
BW body weight, CI confidence intervals, D diet, DBP diastolic blood pressure, D + E diet and exercise, E exercise, FM fat mass, HDL-C high-density lipoprotein
cholesterol, LDL-C low-density lipoprotein cholesterol, SBP systolic blood pressure, TC total cholesterol, TG triacyglycerols, VO2 max maximal oxygen uptake,
WC waist circumference, WHR waist-to-hip ratio.
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There was some evidence of inconsistency for the outcome
LDC (p value = 0.02) although this might be due to chance
since several p values for inconsistency are being calculated
(Additional file 1: Table S8). After inspection of the evi-
dence on this outcome we did not identify a reason for this
apparent inconsistency.
Risk of bias
The dropout rates ranged from 0% to 65%, with 11 out
of 22 trials reporting dropout rates <10% (Table 1).
Pairwise meta-analysis resulted in no significant drop-
out differences (p = 0.37) between D + E (122/1,257) vs.
D (111/1,152), D + E (79/714) vs. D (82/715) (p = 0.96)
and D + E (87/701) vs. D (84/706) (p = 0.34). Eight trials
(nine reports) reported random sequence generation
[34,35,42,43,46,47,50-52], and only two trials reported allo-
cation concealment [42,52]. None of the studies reported
blinding of volunteers towards mode of intervention (not
possible in diet/exercise trials), and four trials (five reports)
appear to have adequate blinding of outcome assessment
[46,47,50-52]. High risk of bias was defined as fewer than
three out of a maximum yield of six low risk of bias items
using the risk of bias assessment tool from the Cochrane
Collaboration. Only seven low risk of bias trials (eight re-
ports) were identified [34,35,42,46,50-52], and sensitivity
analyses were performed for studies with a low risk of bias
(Additional file 1: Table S1).
Sensitivity analysis
Sensitivity analyses (pairwise meta-analysis) were per-
formed for obese, study length ≥24 months, older par-
ticipants (age: ≥50 years) and low risk of bias studies.
Comparison of long-term vs. short-term trials resulted
in smaller reductions in body weight (Additional file 1:
Tables S2-S3). The results of the primary analysis (D + E
vs. D and D vs. E) could be confirmed including only
obese participants (Additional file 1: Table S4), except for
WC and VO2 max. Including only participants ≥50 years
of age (Additional file 1: Table S5), results of the primary
analysis could not be confirmed regarding anthropometric
outcomes when comparing D + E vs. D (only four to eight
trials available), whilst the results of the main analysis for
D vs. E were not affected. Sensitivity analyses excluding
trials with a high risk of bias changed some summary esti-
mates (D + E vs. D) for anthropometric outcomes and
became statistically non-significant (with the exception
of D vs. E comparisons).
Fixed vs. random effects models
Results of the pairwise meta-analyses with a fixed effects
model are presented in Additional file 1: Table S6. Over-
all, the results of the main analysis could be confirmed
in the fixed pairwise sensitivity analyses. However com-
paring D vs. E resulted in a significant reduction in WC,
TC and LDL-C in the fixed effects model, which was not
observed in the random effects model, that were more
pronounced in the D group. However, we note that the
between-study heterogeneity was moderate to high for
these outcomes and therefore the fixed effects model
may not be appropriate.
In the NMA, comparing the DIC for fixed and random
effects models suggests that the fixed effects model
might be appropriate for DBP, SBP, TC, TG and WC
(Additional file 1: Table S7). The estimated treatment ef-
fects using fixed effects network meta-analyses are given
in Additional file 1: Table S6. Some differences could be
observed between the random and fixed effects models.
In the fixed effects model, comparing D vs. E resulted in
a significant reduction in WC, TC, LDL-C, SBP and VO2
max, favouring D (with the exception of VO2 max), com-
pared to the random effects model. Furthermore, the fixed
effects model showed a significant reduction in WHR,
comparing D + E vs. D/E, and increase in HDL-C com-
pared to E. Again, we note that the fixed effects model was
not always considered suitable (Additional file 1: Table S7).
Publication bias
Begg's and Egger's regression tests provided no evidence
of substantial publication bias (data not shown). Funnel
plots were generated only if specific outcome measures
were provided by at least ten different trials (some trials
provide more than one data point for analysis as they re-
port results for subgroups: men and women) [18]. The
plot with respect to effect size change for body weight in
response to D + E vs. D vs. E indicates little asymmetry
(Additional file 1: Figures S2-S3). Thus, publication bias
cannot be completely excluded as a factor affecting the
results of the present meta-analysis.
Discussion
The primary findings of this systematic review and meta-
analysis of long-term trials are that a combination of D + E
is more effective in reducing BW compared to either D or
E in overweight and obese participants. Furthermore, im-
provements in WC, WHR and FM were significantly more
pronounced following D + E compared to either D or E.
The combination of D + E is also the most powerful life-
style intervention to reduce blood lipids and blood pres-
sure. Compared to E, a dietary intervention resulted in
significantly greater reductions in body weight, fat mass
and systolic blood pressure. Pooling both direct and indir-
ect evidence on D+ E, D and E via network meta-analysis
demonstrated that D + E was the most efficacious exercise
intervention regarding its impact on BW, WC, FM, TC,
LDL-C, TG, DBP and VO2 max.
The findings of this meta-analysis, i.e. diet being sig-
nificantly more effective in reducing BW than exercise,
are supported by results of a 2006 Cochrane review [11]
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and are consistent with results of another meta-analysis
[53]. Therefore, caloric restriction appears the most power-
ful method for achieving weight loss in overweight and
obese people. The amount of weight loss yielded by diet
and exercise can be compared to the corresponding results
of the most effective pharmacological interventions such as
orlistat (4.12/3.1 kg at 12 months) [54,55]. A recent
systematic review concluded that orlistat, lorcaserin
and phentermine/topiramate ER when used as an ad-
junct to lifestyle intervention, could induce a clinically
relevant (≥5%) 12-month weight loss [56]. The inter-
pretation of our network meta-analysis is restricted by
the fact that none of the trials evaluated the impact of
their interventions on clinical outcomes. It should be
noted, however, that no anti-obesity drugs have been
shown to have a favourable effect on CVD morbidity
and mortality as well [57]. Furthermore anti-obesity
drugs were associated with increased risk of total adverse
events, tachycardia, gastrointestinal disease, hypertension
and mouth dryness [58].
Previous studies reported that a 5% reduction of BW
is associated with a reduced risk of T2D incidence and
other metabolic disorders. A 5-kg weight loss over time
could account for a 55% reduction in the risk of diabetes
over the mean of 3.2 years of follow-up in a high-risk
population [59]. Regarding visceral adipose tissue, a
comprehensive meta-analysis of cohort studies showed
that a 1-cm increase in WC and a 0.01-U increase in
WHR are associated with a 2%–5% increase in risk of
future CVD [60]. Applying this data to the results of
the present meta-analysis, D + E would be associated
with a CVD risk reduction of ~3%–6%. Improvements
on anthropometric outcomes were more distinct in
younger participants compared with older which might
be explained by the fact that younger participants were
able to perform more intense exercise sessions. How-
ever, since not all trials applied supervised exercise, no
definitive explanation can be given.
With respect to blood lipids, a meta-analysis of 70 stud-
ies indicate that each kilogram of weight loss was associ-
ated with a 1.9 mg/dl decrease in TC and a 0.77 mg/dl
decrease in LDL-C, respectively [61]. Furthermore, RCTs
showed that especially aerobic exercise was associated
with an increase in HDL-C [62]. These associations could
be confirmed in the present meta-analysis.
The predominant dietary intervention implemented in
the included trials was either an energy-restricted low-
fat diet or an energy-balanced moderate-fat diet. In gen-
eral, the composition of diets was approximately at least
500 kcal below the estimated energy need, and fat intake
was ≤30% of total energy content. In the D + E and D
trials, 1,200 kcal for women and 1,500 kcal for men were
generally prescribed. In the dietary intervention trials, gen-
eral guidelines for physical activity were recommended.
However, in the D + E trials, specific goals for physical ac-
tivity/exercise were implemented. Network meta-analyses
provides evidence that a combination of aerobic and resist-
ance training should be recommended in the prevention
and treatment of overweight, obesity and associated
diseases [4,10].
Cardiorespiratory fitness is associated with cardiovas-
cular mortality and cancer in men and women [63,64].
A pooled analysis investigating the effects of cardiorespi-
ratory fitness on all-cause mortality and cardiovascular
events demonstrated that a 1-unit increase in metabolic
equivalents was associated with a 13% and 15% reduc-
tion in risk of all-cause mortality and coronary heart dis-
ease (CHD)/CVD, respectively [65]. Transferring this
data to the results of the present meta-analysis, D + E re-
duced the risk of all-cause mortality by 14% and of
CVD/CHD by 16% and approximately 8% (mortality)
and 9% (CVD/CHD) following applications of single lifestyle
interventions, respectively. A possible explanation of the
superior effect of D + E on cardiorespiratory fitness could
be the greater weight loss induced by caloric restriction.
The present systematic review has several limitations.
A major limitation is that no search for unpublished
studies and any additional data sources and strategies
(author contacts, trial registers) was performed. Another
limitation is the fact that not all potential effect modi-
fiers were accounted for. Often participants in different
arms of trials did not receive equal numbers of contacts.
It could be argued that contact time rather than the spe-
cific elements of the intervention affected participant’s
weight and cardiovascular risk factor outcomes. Hetero-
geneity could be observed for some outcome parame-
ters, probably introduced by differences between trials,
including different D + E regimens. Publication bias can-
not be excluded to affect the results on any meta-analysis;
however, formal statistical testing did not suggest publica-
tion bias for the current analysis. Had there been evidence
of publication bias and if more studies were available, re-
gression techniques could be used to adjust for this [66].
Although many studies included in our analysis had a
substantial dropout rate (see Table 1), intention-to-treat
analyses were generally not conducted. However, drop-
outs were generally similar for all intervention groups.
Taken together, 2/3 of the included trials were judged as
being at high risk of bias. Therefore, the results should
be interpreted in a conservative manner. Strengths of
this research include the application of the network
meta-analysis, as well as the fact that there was no evi-
dence of inconsistency for most outcomes, and an over-
all sample size of 3,521 participants.
Conclusions
The present network meta-analysis provides moderate-
quality evidence that D + E induces moderate long-term
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weight loss and reduces blood lipids and blood pressure
when compared to E or D as single interventional mea-
sures, respectively. In addition, the evidence suggests
moderate superiority of D over E regarding anthropo-
metric outcome parameters. The current findings seem
to be clinically relevant for public health, in particular
for encouraging a combination of diet and exercise for
primary prevention of overweight and obesity. Future
trials should investigate the long-term effects of different
training modalities (aerobic, resistance or combined train-
ing) in combination with dietary interventions for the pre-
vention and treatment of overweight and obesity.
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